Editas Medicine, Inc. financial data

Symbol
EDIT on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 09 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 303% % -24%
Debt-to-equity 605% % 669%
Return On Equity -523% % -361%
Return On Assets -74% % -17%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97,871,999 shares 18%
Common Stock, Shares, Outstanding 97,866,996 shares 18%
Entity Public Float $191,377,146 USD -50%
Common Stock, Value, Issued $10,000 USD 25%
Weighted Average Number of Shares Outstanding, Basic 88,745,908 shares 7.8%
Weighted Average Number of Shares Outstanding, Diluted 88,745,908 shares 7.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $40,520,000 USD 25%
Research and Development Expense $89,953,000 USD -55%
General and Administrative Expense $49,903,000 USD -31%
Operating Income (Loss) $160,010,000 USD 36%
Nonoperating Income (Expense) $50,000 USD -100%
Net Income (Loss) Attributable to Parent $160,060,000 USD 32%
Earnings Per Share, Basic -1.8 USD/shares 38%
Earnings Per Share, Diluted -1.8 USD/shares 38%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $146,645,000 USD 11%
Marketable Securities, Current $0 USD -100%
Assets, Current $163,895,000 USD -43%
Property, Plant and Equipment, Net $3,542,000 USD -76%
Operating Lease, Right-of-Use Asset $16,121,000 USD -50%
Other Assets, Noncurrent $2,976,000 USD -43%
Assets $186,534,000 USD -45%
Accounts Payable, Current $2,605,000 USD -53%
Employee-related Liabilities, Current $5,220,000 USD -55%
Accrued Liabilities, Current $32,610,000 USD -29%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $46,246,000 USD -40%
Contract with Customer, Liability, Noncurrent $44,509,000 USD -18%
Operating Lease, Liability, Noncurrent $12,071,000 USD -41%
Other Liabilities, Noncurrent $2,815,000 USD -8.4%
Liabilities $159,246,000 USD -23%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD -100%
Retained Earnings (Accumulated Deficit) $1,628,503,000 USD -11%
Stockholders' Equity Attributable to Parent $27,288,000 USD -80%
Liabilities and Equity $186,534,000 USD -45%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $47,799,000 USD 4.2%
Net Cash Provided by (Used in) Financing Activities $1,437,000 USD -848%
Net Cash Provided by (Used in) Investing Activities $56,387,000 USD
Common Stock, Shares Authorized 390,000,000 shares 100%
Common Stock, Shares, Issued 97,866,996 shares 18%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $7,151,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $149,315,000 USD 10%
Deferred Tax Assets, Valuation Allowance $432,196,000 USD 11%
Deferred Tax Assets, Gross $436,439,000 USD 9.8%
Operating Lease, Liability $18,102,000 USD -48%
Depreciation $1,917,000 USD 36%
Payments to Acquire Property, Plant, and Equipment $114,000 USD -94%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $160,328,000 USD 32%
Lessee, Operating Lease, Liability, to be Paid $20,465,000 USD -49%
Property, Plant and Equipment, Gross $31,895,000 USD -31%
Operating Lease, Liability, Current $6,031,000 USD -59%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,076,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,389,000 USD -57%
Operating Lease, Weighted Average Discount Rate, Percent 0.092 pure 1.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,363,000 USD -52%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,000,000 USD -15%
Deferred Tax Assets, Operating Loss Carryforwards $231,981,000 USD 36%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $17,099,000 USD 9.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,000,000 USD -15%
Operating Lease, Payments $5,406,000 USD 41%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $4,243,000 USD -50%
Share-based Payment Arrangement, Expense $10,000,000 USD -53%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%